Cargando…
Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure
Heart failure is a common and disabling condition with morbidity and mortality that increase dramatically with advancing age. Large observational studies, retrospective subgroup analyses and meta-analyses of clinical trials in systolic heart failure, and recently published randomized studies have pr...
Autores principales: | Del Sindaco, Donatella, Tinti, Maria Denitza, Monzo, Luca, Pulignano, Giovanni |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998246/ https://www.ncbi.nlm.nih.gov/pubmed/21152240 http://dx.doi.org/10.2147/CIA.S4482 |
Ejemplares similares
-
Atrial fibrillation management in older heart failure patients: a complex clinical problem
por: Pulignano, Giovanni, et al.
Publicado: (2016) -
Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007) -
Exercise: a “new drug” for elderly patients with chronic heart failure
por: Antonicelli, Roberto, et al.
Publicado: (2016) -
Nebivolol therapy improves QTc and QTcd parameters in heart failure patients
por: Aksoy, SM, et al.
Publicado: (2012) -
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
por: Cohen-Solal, Alain, et al.
Publicado: (2009)